Apiam Animal Health - Public Comps and Valuation Multiples

Apiam Animal Health Overview

About Apiam Animal Health

Apiam Animal Health Ltd provides products and services to support the health and welfare of production and mixed animals. The company offers veterinary wholesale, warehousing, logistics, and other ancillary services. Its operating segments include Dairy and Mixed, Feedlots and Pigs. It generates the majority of its revenue from Dairy and Mixed. The Group operates in the segment of provision of veterinary products and services to production, companion and equine animals.

Founded

2015

HQ

Employees

215

Website

apiam.com.au

Sectors

Healthcare Software

Financials

LTM Revenue $137M

LTM EBITDA $14.0M

EV

$161M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Apiam Animal Health Financials

As of August 2025, Apiam Animal Health reported last 12-month revenue of $137M and EBITDA of $14.0M.

In the same period, Apiam Animal Health achieved $1.7M in LTM net income.

See Apiam Animal Health valuation multiples based on analyst estimates

Apiam Animal Health P&L

In the most recent fiscal year, Apiam Animal Health reported revenue of $136M and EBITDA of $13.1M.

Apiam Animal Health expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Apiam Animal Health valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$137M	XXX	$136M	XXX	XXX	XXX
Gross Profit	n/a	XXX	$89.8M	XXX	XXX	XXX
Gross Margin	n/a	XXX	66%	XXX	XXX	XXX
EBITDA	$14.0M	XXX	$13.1M	XXX	XXX	XXX
EBITDA Margin	10%	XXX	10%	XXX	XXX	XXX
EBIT	$9.6M	XXX	$8.2M	XXX	XXX	XXX
EBIT Margin	7%	XXX	6%	XXX	XXX	XXX
Net Profit	$1.7M	XXX	$0.5M	XXX	XXX	XXX
Net Margin	1%	XXX	0%	XXX	XXX	XXX
Net Debt	XXX	XXX	$38.6M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Apiam Animal Health including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $137M. EBITDA for the last twelve months was $14.0M. In the most recent fiscal year, Apiam Animal Health achieved $136M in revenue and $13.1M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$137M	Analyst estimates available to subscribers	$136M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	n/a	Analyst estimates available to subscribers	$89.8M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	n/a	Analyst estimates available to subscribers	66.2% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$14.0M	Analyst estimates available to subscribers	$13.1M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	10.2% EBITDA margin	Analyst estimates available to subscribers	9.6% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$9.6M	Analyst estimates available to subscribers	$8.2M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	7.0% EBIT margin	Analyst estimates available to subscribers	6.0% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$1.7M	Analyst estimates available to subscribers	$0.5M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	1.2% net profit margin	Analyst estimates available to subscribers	0.4% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	$38.6M	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Apiam Animal Health

This financial data table provides comprehensive performance metrics for Apiam Animal Health, a company based in Australia. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Apiam Animal Health generated $137M in revenue over the last twelve months.
The company achieved $14.0M in EBITDA over the last twelve months.
Net income over the last twelve months reached $1.7M.

Fiscal Year Performance

In the most recent fiscal year, Apiam Animal Health reported $136M in total revenue.
Fiscal year EBITDA was $13.1M.
The company maintained a gross profit margin of 66.2% in the most recent fiscal year.
EBITDA margin for the fiscal year was 9.6%.
Net profit margin reached 0.4% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Apiam Animal Health. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Apiam Animal Health Stock Performance

Apiam Animal Health has current market cap of AUD 145M (or $95.2M), and EV of AUD 245M (or $161M).

Market Cap Evolution

Apiam Animal Health Stock Data

As of September 19, 2025, Apiam Animal Health's stock price is AUD 1 (or $1).

See Apiam Animal Health trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$161M	$95.2M	XXX	XXX	XXX	XXX	$0.01

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Apiam Animal Health Valuation Multiples

Apiam Animal Health's trades at 1.2x EV/Revenue multiple, and 11.3x EV/EBITDA.

See valuation multiples for Apiam Animal Health and 15K+ public comps

Apiam Animal Health Financial Valuation Multiples

As of September 19, 2025, Apiam Animal Health has market cap of $95.2M and EV of $161M.

Equity research analysts estimate Apiam Animal Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Apiam Animal Health has a P/E ratio of 56.3x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$95.2M	XXX	$95.2M	XXX	XXX	XXX
EV (current)	$161M	XXX	$161M	XXX	XXX	XXX
EV/Revenue	1.2x	XXX	1.2x	XXX	XXX	XXX
EV/EBITDA	11.5x	XXX	11.3x	XXX	XXX	XXX
EV/EBIT	16.7x	XXX	19.8x	XXX	XXX	XXX
EV/Gross Profit	n/a	XXX	n/a	XXX	XXX	XXX
P/E	56.3x	XXX	50.4x	XXX	XXX	XXX
EV/FCF	10.5x	XXX	19.8x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Apiam Animal Health Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Apiam Animal Health Margins & Growth Rates

Apiam Animal Health's last 12 month revenue growth is 4%

Apiam Animal Health's revenue per employee in the last FY averaged $0.6M, while opex per employee averaged $0.4M for the same period.

Apiam Animal Health's rule of 40 is 15% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Apiam Animal Health's rule of X is 20% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Apiam Animal Health and other 15K+ public comps

Apiam Animal Health Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	4%	XXX	3%	XXX	XXX	XXX
EBITDA Margin	10%	XXX	11%	XXX	XXX	XXX
EBITDA Growth	7%	XXX	3%	XXX	XXX	XXX
Rule of 40	15%	XXX	15%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	20%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.6M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.4M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	60%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial